Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of two angiographic contrast agents for prevention of contrast-induced nephropathy
2005-001986-32Phase 4Terminated
- Sponsor
- NHS Tayside
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of angiographic iodinated contrast agent A and iohexol in contrast-induced nephropathy (CIN) and acute kidney failure (AKF) (2 arms), sponsored by NHS Tayside. Primary endpoint: Renal function at 48–72 hours post-procedure. Started Jun 2005; status: terminated.
02
Drugs
angiographic iodinated contrast agent Aiohexol
03
Conditions
contrast-induced nephropathy (CIN)acute kidney failure (AKF)
Beyond the preview
Go deeper on 2005-001986-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001986-32.